Literature DB >> 16680152

The inner-nuclear-envelope protein emerin regulates HIV-1 infectivity.

Jean-Marc Jacque1, Mario Stevenson.   

Abstract

Primate lentiviruses such as human immunodeficiency type 1 (HIV-1) have the capacity to infect non-dividing cells such as tissue macrophages. In the process, viral complementary DNA traverses the nuclear envelope to integrate within chromatin. Given the intimate association between chromatin and the nuclear envelope, we examined whether HIV-1 appropriates nuclear envelope components during infection. Here we show that emerin, an integral inner-nuclear-envelope protein, is necessary for HIV-1 infection. Infection of primary macrophages lacking emerin was abortive in that viral cDNA localized to the nucleus but integration into chromatin was inefficient, and conversion of viral cDNA to non-functional episomal cDNA increased. HIV-1 cDNA associated with emerin in vivo, and the interaction of viral cDNA with chromatin was dependent on emerin. Barrier-to-autointegration factor (BAF), the LEM (LAP, emerin, MAN) binding partner of emerin, was required for the association of viral cDNA with emerin and for the ability of emerin to support virus infection. Therefore emerin, which bridges the interface between the inner nuclear envelope and chromatin, may be necessary for chromatin engagement by viral cDNA before integration.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16680152     DOI: 10.1038/nature04682

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  48 in total

1.  Retrotransposon suicide: formation of Ty1 circles and autointegration via a central DNA flap.

Authors:  David J Garfinkel; Karen M Stefanisko; Katherine M Nyswaner; Sharon P Moore; Jangsuk Oh; Stephen H Hughes
Journal:  J Virol       Date:  2006-09-27       Impact factor: 5.103

2.  Myeloid differentiation and susceptibility to HIV-1 are linked to APOBEC3 expression.

Authors:  Gang Peng; Teresa Greenwell-Wild; Salvador Nares; Wenwen Jin; Ke Jian Lei; Zoila G Rangel; Peter J Munson; Sharon M Wahl
Journal:  Blood       Date:  2007-03-19       Impact factor: 22.113

3.  Retrotransposon target site selection by imitation of a cellular protein.

Authors:  Troy L Brady; Peter G Fuerst; Robert A Dick; Clarice Schmidt; Daniel F Voytas
Journal:  Mol Cell Biol       Date:  2007-12-17       Impact factor: 4.272

Review 4.  RNA interference and antiviral therapy.

Authors:  Yan Ma; Chu-Yan Chan; Ming-Liang He
Journal:  World J Gastroenterol       Date:  2007-10-21       Impact factor: 5.742

5.  Ku80 participates in the targeting of retroviral transgenes to the chromatin of CHO cells.

Authors:  Christel Masson; Stéphanie Bury-Moné; Elvire Guiot; Asier Saez-Cirion; Damien Schoëvaërt-Brossault; Corinne Brachet-Ducos; Olivier Delelis; Frédéric Subra; Laurence Jeanson-Leh; Jean-François Mouscadet
Journal:  J Virol       Date:  2007-05-16       Impact factor: 5.103

Review 6.  Integrase, LEDGF/p75 and HIV replication.

Authors:  E M Poeschla
Journal:  Cell Mol Life Sci       Date:  2008-05       Impact factor: 9.261

Review 7.  Integration-deficient lentiviral vectors: a slow coming of age.

Authors:  Klaus Wanisch; Rafael J Yáñez-Muñoz
Journal:  Mol Ther       Date:  2009-06-02       Impact factor: 11.454

8.  Induction of interleukins IL-6 and IL-8 by siRNA.

Authors:  E Pauls; J Senserrich; M Bofill; B Clotet; J A Esté
Journal:  Clin Exp Immunol       Date:  2007-01       Impact factor: 4.330

Review 9.  Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin.

Authors:  Thomas Dechat; Katrin Pfleghaar; Kaushik Sengupta; Takeshi Shimi; Dale K Shumaker; Liliana Solimando; Robert D Goldman
Journal:  Genes Dev       Date:  2008-04-01       Impact factor: 11.361

Review 10.  Lamins and Lamin-Associated Proteins in Gastrointestinal Health and Disease.

Authors:  Graham F Brady; Raymond Kwan; Juliana Bragazzi Cunha; Jared S Elenbaas; M Bishr Omary
Journal:  Gastroenterology       Date:  2018-03-13       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.